Antibodies.com Supercharges UK Operations with Move to Larger Cambridge HQ

Antibodies.com, a leading provider of high-quality reagents for life science research, has today announced the opening of its new UK headquarters at Cambridge Technopark, a significant expansion that marks a new chapter in the company’s rapid global growth.

The new 5,000 sq. ft facility, five times larger than its previous site, is designed to boost the company’s logistics, research and development (R&D), and operational capabilities, as it continues to scale with rising international demand. The move reinforces Antibodies.com’s position within the UK’s thriving biotech cluster and enhances its ability to deliver faster, more customizable solutions to scientists worldwide.

“This relocation isn’t just about more space, it’s about unlocking greater potential for innovation and service,” said Dr Stewart Newlove, Chief Technology Officer and Co-Founder of Antibodies.com. “Our new headquarters in the heart of Cambridge’s life sciences community allows us to scale more effectively, improve turnaround times, and continue supporting researchers at the forefront of antibody therapeutics.”

Founded to meet the growing demand for affordable, high-performance biological reagents, Antibodies.com has tripled its global customer base in the last five years and now supports over 5,000 research institutions in more than 100 countries. Its extensive product catalogue, featuring over 100,000 items including antibodies, proteins, and ELISA kits, has become a go-to resource for scientists conducting cutting-edge biomedical research.

The newly designed headquarters features expanded laboratory and logistics spaces, upgraded infrastructure to improve inventory and fulfilment systems, and state-of-the-art R&D facilities. Designed with sustainability and collaboration in mind, the space also includes shared meeting areas, breakout zones, and secure cycle storage, all aimed at fostering a dynamic and environmentally conscious workplace.

With additional offices in Stockholm, Sweden, and St. Louis, USA, this expansion solidifies Antibodies.com’s international footprint while reaffirming its commitment to customer-centric innovation and operational excellence.